Skip to main content
OpenTrials
Completed

NCT Number: NCT02422420

Minnesota Medicaid Incentives to Prevent Chronic Disease

The objective of this study is to test whether two different participant financial incentive structures are more effective and cost effective than minimal financial incentives in increasing weight loss among Minnesota Medicaid beneficiaries at high risk of developing diabetes. The incentives are tied to participation and weight loss in the evidence-based group-delivered YMCA diabetes prevention program (Y-DPP). The Investigators will conduct a group randomized trial that includes up to 150 Y-DPP classes of 10-15 participants per class for up to 1500 Medicaid beneficiaries participating in the Y-DPP classes. This approach, if successful, will (a) improve weight loss. diabetes risk, and improve cardiovascular risk among Medicaid beneficiaries at risk for developing diabetes and other chronic conditions, (b) demonstrate that prevention of chronic disease risk factors using patient incentives is cost-effective, and (c) provide a patient incentive model that can be widely used among Medicaid beneficiaries at risk for developing diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prediabetic State Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minnesota Department of Health

Saint Paul, Minnesota, 55164-0882, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • currently enrolled in Medical Assistance, PMAP, or MinnesotaCare (collectively referred to as Medicaid)
  • 18-75 years of age
  • body mass index ≥ 25 kg/m2 (≥ 22 kg/m2 for those of Asian descent)
  • have prediabetes or a history of gestational diabetes mellitus (GDM)

Exclusion criteria

  • diagnosis of diabetes
  • pregnant at the time of enrollment
  • planning gastric bypass surgery within the next 12 months
  • diagnosed with Alzheimer's disease (ICD-9 331.0) or dementia (ICD-9 290.0 - 294.9)
  • provider judgment regarding suitability for the study based on substance abuse, uncontrolled mental illness, or other conditions that may affect the participants health or ability to participate in the study.

Treatment and study plan

Financial Incentives

Behavioral

Use of financial incentives to promote health behaviors.

Primary outcomes

  1. DPP Attendance

    Time frame: 12 months

    Participation in DPP core and post-core sessions

  2. Weight Change

    Time frame: 12 months

    Change in participants' weight

Sponsors and collaborators

Lead sponsor

Minnesota Department of Human Services

Other Gov

Collaborators

  • HealthPartners Institute
  • Minnesota Department of Health

Registry information

Acronym: MMIPCD

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Apr 21, 2015
Registry last updated
Oct 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.